LISOCABTAGENE MARALEUCEL vs LOMITAPIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE: Safety Overview
| Metric | LISOCABTAGENE MARALEUCEL | LOMITAPIDE |
|---|---|---|
| Total FAERS Reports | 738 | 3,779 |
| Deaths Reported | 132 | 109 |
| Death Rate | 17.9% | 2.9% |
| Hospitalizations | 396 | 434 |
| Average Patient Age | 66.3 yrs | 54.6 yrs |
| % Female Patients | 36.8% | 66.5% |
| FDA Approval Date | N/A | Apr 23, 2015 |
| Manufacturer | Juno Therapeutics, Inc. | Amryt Pharmaceuticals DAC |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |